BIOGEN PHARMACHEM INDUSTRIES LIMITED

BIOGEN PHARMACHEM INDUSTRIES LIMITED (NSE/BSE: BIOGEN) is an Indian publicly listed company quoted on the Bombay Stock Exchange (BSE). The company operates in healthcare, a sector that combines regulated pricing with long-run demand growth from a rising domestic patient base. Its securities trade under ISIN INE703D01023. As of the most recent update, BIOGEN PHARMACHEM INDUSTRIES LIMITED carries an equity market capitalisation of approximately ₹92.89 Cr, which places it among the tracked constituents of the Healthcare sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by BIOGEN PHARMACHEM INDUSTRIES LIMITED via stock-exchange filings. For investors and researchers tracking healthcare listings, BIOGEN provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates BIOGEN PHARMACHEM INDUSTRIES LIMITED's core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.